Technology

ALL-IN-ONE APPROACH
We need a paradigm shift in treatment and prevention of viruses!

Novelgen with exclusive antibody engineering technologies
has developed NVG308 mini-antibody, the World’s first broad-spectrum antiviral medicine,
and dedicated to develop novel antiviral therapeutics to deal with variable viral species.

We have identified MOA(Mode of Action) of the mini-antibody and secured proprietary technologies
to develop next-generation antiviral therapeutics. The mini-antibody can prevent and cure viral infections
irrespective of viral species, discriminating it from existing treatments
which have showed limitations in tackling emerging viruses to evade the treatments.